Emily Mullin

The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical disabilities to have more natural interactions with the world around them.

The DOGE-mandated credit card freeze is delaying shipments of critical supplies, stalling travel, and stopping employees from doing their jobs.

With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the avian influenza outbreak.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Biohacker Josie Zyner’s new company, Los Angeles Project, is creating a new generation of gene-edited pets.

Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as desire itself.

In its notice outlining the large cut in university funding, the US National Institutes of Health seems to draw on a report from a conservative think tank that denounces the “political left.”

The journal’s editorial board includes multiple scientists, such as Trump health nominees Jay Bhattacharya and Marty Makary, who opposed Covid public health measures.

During his confirmation hearings this week, Robert F. Kennedy Jr. said he would promote vaccines as HHS secretary, despite a long history of promoting anti-vax positions.